Driss Chaoui
Argenteuil, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Beyond Frailty Scores: Unmet Needs and Tailored Treatment Strategies in Patients With Chronic Lymphocytic Leukemia Aged ≥ 80 Years.
Journal: European journal of haematology
Published: April 18, 2026
The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 03, 2025
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia.
Journal: Leukemia
Published: June 03, 2025
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020.
Journal: Cancer medicine
Published: October 04, 2024
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.
Journal: EJHaem
Published: September 15, 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Journal: Haematologica
Published: October 14, 2022
Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: February 18, 2021
Last Updated: 09/26/2026